neo

 The cookie jar brims with intangibles and goodwill from two 2021 acquisitions that have not been market to market, model, or can be serviced with operating losses

Intangible assets, net						433,835						442,325
Goodwill						527,115						527,115
Other assets						6,600						7,168
Total non-current assets						1,178,447						1,188,270
Total assets						$	1,829,547					$	1,869,778

half a billion raised with converts that have a strike price a bomb blast away which come with the present of $100 million paid for equity caps

Convertible senior notes, net

533,189

532,483

quarterly revenue $117 million

Total net revenue

117,169

115,533

loss from ops that doubled with revenue flat

LOSS FROM OPERATIONS

(52,028)

(15,107)

a patent infringement suit against one of the 2021 aquisitions. the plaintiff has a story of its own

On January 20, 2021, Natera, Inc. filed a patent infringement complaint against the Company’s newly-acquired subsidiary Inivata Limited and its subsidiary Inivata, Inc. in United States District Court for the district of Delaware, alleging Inivata’s InVisionFirst-Lung™ cancer diagnostic test of infringing two patents.

what appears to be a confession of  regulatory fraud with the prayer of an $11 million reserve 

Company voluntarily notified the Office of Inspector General of the U.S. Department of Health and Human Services (“OIG”) of the Company’s internal investigation in November 2021. The Company’s review of this matter is ongoing. The Company has a reserve of $11.2 million in other long-term liabilities as of March 31, 2022 and December 31, 2021 on the Consolidated Balance Sheets for potential damages and liabilities primarily associated with the federal healthcare program revenue received by the Company in connection with the agreements at issue that were identified during the course of this internal investigation.

all for the going rate of a $1 billion market cap